Literature DB >> 33571729

Pathways to understanding psychosis through rare - 22q11.2DS - and common variants.

Raquel E Gur1, David R Roalf2, Aaron Alexander-Bloch2, Donna M McDonald-McGinn3, Ruben C Gur2.   

Abstract

The 22q11.2 Deletion Syndrome has significant impact on brain and behavior, with about 25% of individuals developing schizophrenia. The condition offers a model for prospective studies on the emergence of psychosis and advancing mechanistic hypotheses on gene-environment interactions, with magnified power for examining genome-phenome association. Here, we highlight findings that build on the International 22q11.2 Brain and Behavior Consortium and relate to several key domains in the study of psychosis-risk and schizophrenia. We examine neurocognition, olfaction and neuroimaging data that indicate similar impairment patterns in this rare syndrome and idiopathic presentation of schizophrenia. We conclude that the converging paradigms, studying psychosis dimensionally in rare and common variants samples, provide complementary approaches that will propel precision medicine in psychiatry.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2021        PMID: 33571729      PMCID: PMC8728946          DOI: 10.1016/j.gde.2021.01.007

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  37 in total

1.  Recent developments in understanding the relationship between 22q11.2 deletion syndrome and psychosis.

Authors:  Linda O'Rourke; Kieran C Murphy
Journal:  Curr Opin Psychiatry       Date:  2019-03       Impact factor: 4.741

2.  Corrigendum to "The dimensional structure of psychopathology in 22q11.2 Deletion Syndrome" [J. Psychiatr. Res. 92 (2017) 124-131].

Authors:  Maria Niarchou; Tyler M Moore; Sunny X Tang; Monica E Calkins; Donna M McDonald-McGuinn; Elaine H Zackai; Beverly S Emanuel; Ruben C Gur; Raquel E Gur
Journal:  J Psychiatr Res       Date:  2019-08-21       Impact factor: 4.791

Review 3.  Meta-analysis of olfactory dysfunction in 22q11.2 deletion syndrome.

Authors:  Paul J Moberg; Bruce I Turetsky; Emily A Moberg; Christian G Kohler; Sunny X Tang; Ruben C Gur; Raquel E Gur; David R Roalf
Journal:  Psychiatry Res       Date:  2020-01-16       Impact factor: 3.222

4.  Systematic review and multi-modal meta-analysis of magnetic resonance imaging findings in 22q11.2 deletion syndrome: Is more evidence needed?

Authors:  Cristina Scarpazza; Guido Maria Lattanzi; Mathilde Antoniades; Fabio Di Fabio; Giuseppe Sartori; Simon B Eickhoff; Philip McGuire; Stefania Tognin
Journal:  Neurosci Biobehav Rev       Date:  2019-09-04       Impact factor: 8.989

5.  The characteristics of palate and upper dental arch can be an anatomical marker for men with schizophrenia? Case-control study: Palate can be a marker for schizophrenia?

Authors:  Rafael Zancan Mobile; Ana Clelia Roussenq; Melissa Rodrigues de Araujo; Ricardo Sbalqueiro; José Vinícius Bolognesi Maciel; Antonio Adilson Soares de Lima
Journal:  Spec Care Dentist       Date:  2020-07-03

6.  Magnitude and heterogeneity of brain structural abnormalities in 22q11.2 deletion syndrome: a meta-analysis.

Authors:  Maria Rogdaki; Maria Gudbrandsen; Declan G M Murphy; Oliver Howes; Robert A McCutcheon; Charlotte E Blackmore; Stefan Brugger; Christine Ecker; Michael C Craig; Eileen Daly
Journal:  Mol Psychiatry       Date:  2020-01-10       Impact factor: 15.992

7.  Transcriptomic and cellular decoding of regional brain vulnerability to neurogenetic disorders.

Authors:  Jakob Seidlitz; Ajay Nadig; Siyuan Liu; Richard A I Bethlehem; Petra E Vértes; Sarah E Morgan; František Váša; Rafael Romero-Garcia; François M Lalonde; Liv S Clasen; Jonathan D Blumenthal; Casey Paquola; Boris Bernhardt; Konrad Wagstyl; Damon Polioudakis; Luis de la Torre-Ubieta; Daniel H Geschwind; Joan C Han; Nancy R Lee; Declan G Murphy; Edward T Bullmore; Armin Raznahan
Journal:  Nat Commun       Date:  2020-07-03       Impact factor: 14.919

Review 8.  A Mini Review on the Contribution of the Anterior Cingulate Cortex in the Risk of Psychosis in 22q11.2 Deletion Syndrome.

Authors:  Maria C Padula; Elisa Scariati; Marie Schaer; Stephan Eliez
Journal:  Front Psychiatry       Date:  2018-08-17       Impact factor: 4.157

9.  A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium.

Authors:  R E Gur; A S Bassett; D M McDonald-McGinn; C E Bearden; E Chow; B S Emanuel; M Owen; A Swillen; M Van den Bree; J Vermeesch; J A S Vorstman; S Warren; T Lehner; B Morrow
Journal:  Mol Psychiatry       Date:  2017-08-01       Impact factor: 15.992

10.  Variance of IQ is partially dependent on deletion type among 1,427 22q11.2 deletion syndrome subjects.

Authors:  Yingjie Zhao; Tingwei Guo; Ania Fiksinski; Elemi Breetvelt; Donna M McDonald-McGinn; Terrence B Crowley; Alexander Diacou; Maude Schneider; Stephan Eliez; Ann Swillen; Jeroen Breckpot; Joris Vermeesch; Eva W C Chow; Doron Gothelf; Sasja Duijff; Rens Evers; Thérèse A van Amelsvoort; Marianne van den Bree; Michael Owen; Maria Niarchou; Carrie E Bearden; Claudia Ornstein; Maria Pontillo; Antonino Buzzanca; Stefano Vicari; Marco Armando; Kieran C Murphy; Clodagh Murphy; Sixto Garcia-Minaur; Nicole Philip; Linda Campbell; Jaume Morey-Cañellas; Jasna Raventos; Jordi Rosell; Damian Heine-Suner; Robert J Shprintzen; Raquel E Gur; Elaine Zackai; Beverly S Emanuel; Tao Wang; Wendy R Kates; Anne S Bassett; Jacob A S Vorstman; Bernice E Morrow
Journal:  Am J Med Genet A       Date:  2018-10-05       Impact factor: 2.802

View more
  1 in total

1.  Copy Number Variant Risk Scores Associated With Cognition, Psychopathology, and Brain Structure in Youths in the Philadelphia Neurodevelopmental Cohort.

Authors:  Aaron Alexander-Bloch; Guillaume Huguet; Laura M Schultz; Nicholas Huffnagle; Sebastien Jacquemont; Jakob Seidlitz; Zohra Saci; Tyler M Moore; Richard A I Bethlehem; Josephine Mollon; Emma K Knowles; Armin Raznahan; Alison Merikangas; Barbara H Chaiyachati; Harshini Raman; J Eric Schmitt; Ran Barzilay; Monica E Calkins; Russel T Shinohara; Theodore D Satterthwaite; Ruben C Gur; David C Glahn; Laura Almasy; Raquel E Gur; Hakon Hakonarson; Joseph Glessner
Journal:  JAMA Psychiatry       Date:  2022-07-01       Impact factor: 25.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.